Intuitive Surgical Inc designs, manufactures and markets the da Vinci surgical system and related instruments and accessories, which is an advanced robot-assisted surgical system. The surgical system comprises a surgeon's console, patient-side cart, 3-D vision system, da Vinci Skills Simulator and Firefly Fluorescence Imaging. Intuitive Surgical's robot-based da Vinci surgical system enables minimally-invasive surgery that reduces the trauma associated with open surgery. The company also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures.?Additionally, the company sells various accessories comprising sterile drapes and vision products and other items that facilitate use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. The company operates through three segments: Instruments and Accessories, Systems and Services.
| Revenue (Most Recent Fiscal Year) | $8.35B |
| Net Income (Most Recent Fiscal Year) | $2.32B |
| PE Ratio (Current Year Earnings Estimate) | 82.15 |
| PE Ratio (Trailing 12 Months) | 80.39 |
| PEG Ratio (Long Term Growth Estimate) | 5.43 |
| Price to Sales Ratio (Trailing 12 Months) | 21.06 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 10.67 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 64.11 |
| Pre-Tax Margin (Trailing 12 Months) | 32.17% |
| Net Margin (Trailing 12 Months) | 28.41% |
| Return on Equity (Trailing 12 Months) | 14.43% |
| Return on Assets (Trailing 12 Months) | 12.81% |
| Current Ratio (Most Recent Fiscal Quarter) | 4.98 |
| Quick Ratio (Most Recent Fiscal Quarter) | 3.97 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 1.94 |
| Book Value per Share (Most Recent Fiscal Quarter) | $46.41 |
| Earnings per Share (Most Recent Fiscal Quarter) | $1.41 |
| Earnings per Share (Most Recent Fiscal Year) | $6.48 |
| Diluted Earnings per Share (Trailing 12 Months) | $6.82 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Common Shares Outstanding | 358.42M |
| Free Float | 355.91M |
| Market Capitalization | $183.55B |
| Average Volume (Last 20 Days) | 1.58M |
| Beta (Past 60 Months) | 1.67 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 0.70% |
| Percentage Held By Institutions (Latest 13F Reports) | 83.64% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |